MON-222 URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (nGAL) IN EARLY ACUTE KIDNEY INJURY (AKI) PREDICTS PROGRESSION AND NEED FOR DIALYSIS

Predicting the progression of acute kidney injury (AKI) and need for renal replacement therapy (RRT) in early stages of AKI would be a useful bedside tool for clinicians, especially in resource-limited countries to optimize resource utilisation. We tested the predictive value of urine neutrophil gelatinase-associated lipocalin (NGAL) measured in the AKI stages 1 and 2, to predict progression of AKI and need for RRT.